Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- Sarasota Memorial Hospital
Sarasota, Florida, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Sudarshan K Sharma Md Limited-Gynecologic Oncology
Hinsdale, Illinois, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Greater Baltimore Medical Center
Baltimore, Maryland, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- Michigan Cancer Research Consortium Ncorp
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Saint Mary Mercy Hospital
Livonia, Michigan, United States
- Saint Joseph Mercy Oakland
Pontiac, Michigan, United States
- Lake Huron Medical Center
Port Huron, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Coxhealth South Hospital
Springfield, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
- Cooper Hospital University Medical Center
Camden, New Jersey, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Summa Akron City Hospital/cooper Cancer Center
Akron, Ohio, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- Kettering Medical Center
Kettering, Ohio, United States
- Uh Seidman Cancer Center at Lake Health Mentor Campus
Mentor, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- West Penn Hospital
Pittsburgh, Pennsylvania, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- Baylor All Saints Medical Center at Fort Worth
Fort Worth, Texas, United States
- Lyndon Baines Johnson General Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Apr 2011
- Primary completion
- 28 Feb 2014
- Completion
- 28 Feb 2014
- Last update posted
- 20 Mar 2019
- Registered enrollment
- 31
- Registry id
- NCT01267253
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.